The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dahan Michel since 2016.
This trader's CIK number is 1669737.
At the time of last reporting, Dahan Michel was the SVP, Chief Operating Officer of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AKBA | 0 | $0 | 54,245 | $73,912 | 0 | $0 |
| 2023 | AKBA | 0 | $0 | 125,980 | $142,893 | 0 | $0 |
| 2022 | AKBA | 0 | $0 | 21,533 | $46,643 | 0 | $0 |
| 2021 | AKBA | 0 | $0 | 15,758 | $53,518 | 0 | $0 |
| 2020 | AKBA | 0 | $0 | 6,972 | $60,656 | 0 | $0 |
| 2017 | AKBA | 0 | $0 | 15,827 | $248,849 | 0 | $0 |
| 2016 | AKBA | 0 | $0 | 4,204 | $36,196 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-13 | AKBA | Sale | 34,840 | 1.26 | 43,898 |
| 2024-02-29 | AKBA | Sale | 8,661 | 1.58 | 13,684 |
| 2024-02-27 | AKBA | Sale | 10,744 | 1.52 | 16,330 |
| 2023-05-25 | AKBA | Sale | 95,478 | 1.22 | 116,769 |
| 2023-03-01 | AKBA | Sale | 20,412 | .88 | 17,921 |
| 2023-02-27 | AKBA | Sale | 10,090 | .81 | 8,203 |
| 2022-02-28 | AKBA | Sale | 6,555 | 2.15 | 14,126 |
| 2022-03-01 | AKBA | Sale | 14,978 | 2.17 | 32,517 |
| 2021-04-01 | AKBA | Sale | 1,211 | 3.40 | 4,117 |
| 2021-03-01 | AKBA | Sale | 14,547 | 3.40 | 49,401 |
| 2020-02-28 | AKBA | Sale | 6,972 | 8.70 | 60,656 |
| 2017-10-02 | AKBA | Sale | 1,398 | 19.64 | 27,456 |
| 2017-09-28 | AKBA | Sale | 5,000 | 19.30 | 96,500 |
| 2017-08-15 | AKBA | Sale | 5,000 | 15.00 | 75,000 |
| 2017-07-03 | AKBA | Sale | 1,399 | 14.26 | 19,946 |
| 2017-04-03 | AKBA | Sale | 1,401 | 9.18 | 12,858 |
| 2017-01-01 | AKBA | Sale | 1,629 | 10.49 | 17,089 |
| 2016-10-01 | AKBA | Sale | 1,401 | 8.96 | 12,545 |
| 2016-07-05 | AKBA | Sale | 1,402 | 7.47 | 10,468 |
| 2016-04-04 | AKBA | Sale | 1,401 | 9.41 | 13,183 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dahan Michel (SVP, Chief Operating Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.